0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Targeted Therapy Drugs Market Research Report 2026
Published Date: 2026-01-08
|
Report Code: QYRE-Auto-6V20402
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Molecule Targeted Therapy Drugs Market Research Report 2026
BUY CHAPTERS

Global Small Molecule Targeted Therapy Drugs Market Research Report 2026

Code: QYRE-Auto-6V20402
Report
2026-01-08
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Molecule Targeted Therapy Drugs Market Size

The global Small Molecule Targeted Therapy Drugs market was valued at US$ 78546 million in 2025 and is anticipated to reach US$ 126575 million by 2032, at a CAGR of 7.3% from 2026 to 2032.

Small Molecule Targeted Therapy Drugs Market

Small Molecule Targeted Therapy Drugs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Small Molecule Targeted Therapy Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global Small Molecule Targeted Therapy Drugs reached approximately 34.54 M Units, with an average global market price of around 2274 USD per Unit.
Small molecule targeted therapy drugs are low-molecular-weight pharmaceutical compounds designed to selectively inhibit or modulate specific molecular targets—such as enzymes, kinases, receptors, or signaling pathways—that play a key role in the development or progression of disease. Their small size allows them to penetrate cell membranes, enabling them to act on intracellular targets that are not accessible to larger biologic drugs.
These therapies are most widely used in oncology, where they commonly block cancer-driving pathways (for example, kinase signaling or DNA repair mechanisms), but they are also increasingly important in autoimmune diseases, inflammatory conditions, and rare genetic disorders. Small molecule targeted therapies are typically orally administered, have well-defined chemical structures, and are developed using advances in medicinal chemistry, structural biology, and molecular diagnostics to align treatment with specific disease mechanisms.
Small molecule targeted therapy drugs address several long-standing industry pain points by offering precise, mechanism-based intervention while retaining the practical advantages of oral administration, predictable pharmacology, and scalable chemical manufacturing. Their ability to penetrate cells allows them to reach intracellular targets that are inaccessible to biologics, making them especially effective against complex signaling pathways involved in cancer, autoimmune disorders, and rare genetic diseases, while often reducing the broad toxicity associated with non-specific treatments. Industry momentum is driven by rapid advances in genomics and molecular biology, improved target validation, and growing clinical confidence in biomarker-guided therapy, alongside healthcare system demand for treatments that balance efficacy, patient convenience, and long-term cost control. Looking forward, the market potential for small molecule targeted therapies remains strong as next-generation compounds address resistance mechanisms, expand into earlier lines of treatment and non-oncology indications, and benefit from global manufacturing and distribution efficiencies, positioning this class as a durable and innovative cornerstone of modern precision medicine.
The upstream raw materials for small molecular targeted therapy drugs mainly include active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and excipients. Typical suppliers include Pfizer, Roche, Merck, and AstraZeneca. Downstream applications are primarily in oncology and rare disease treatments.
The single-line production capacity of small molecular targeted therapy drugs varies significantly depending on the drug molecule type, process complexity, equipment scale, and production mode. Industry gross margins typically range from 60% to 80%.
The North American market for Small Molecule Targeted Therapy Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Small Molecule Targeted Therapy Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Small Molecule Targeted Therapy Drugs include Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Small Molecule Targeted Therapy Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Small Molecule Targeted Therapy Drugs. The Small Molecule Targeted Therapy Drugs market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Small Molecule Targeted Therapy Drugs market comprehensively. Regional market sizes by Type, by Application, by Administration Route, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Small Molecule Targeted Therapy Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Small Molecule Targeted Therapy Drugs Market Report

Report Metric Details
Report Name Small Molecule Targeted Therapy Drugs Market
Accounted market size in 2025 US$ 78546 million
Forecasted market size in 2032 US$ 126575 million
CAGR 7.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Kinase Inhibitors
  • Others
Segment by Administration Route
  • Oral Drugs
  • Injectable Drugs
  • Others
Segment by Raw Materials
  • Synthetic Drugs
  • Natural Drugs
by Application
  • Cancer Diseases
  • Immune Diseases
  • Cardiovascular Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, Amgen, Eli Lilly and Company, AbbVie, Sanofi, Takeda, Boehringer Ingelheim, Beigene, Ltd., Jiangsu Hengrui Medicine, INNOVENT BIOLOGICS(SUZHOU), Betta Pharmaceuticals, Remegen Co.,Ltd., Shanghai Allist Pharmaceuticals, Innocare, Huiyu Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Administration Route, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Small Molecule Targeted Therapy Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Small Molecule Targeted Therapy Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Small Molecule Targeted Therapy Drugs Market growing?

Ans: The Small Molecule Targeted Therapy Drugs Market witnessing a CAGR of 7.3% during the forecast period 2026-2032.

What is the Small Molecule Targeted Therapy Drugs Market size in 2032?

Ans: The Small Molecule Targeted Therapy Drugs Market size in 2032 will be US$ 126575 million.

Who are the main players in the Small Molecule Targeted Therapy Drugs Market report?

Ans: The main players in the Small Molecule Targeted Therapy Drugs Market are Roche, Novartis, Merck, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Bayer, GSK, Daiichi Sankyo, Amgen, Eli Lilly and Company, AbbVie, Sanofi, Takeda, Boehringer Ingelheim, Beigene, Ltd., Jiangsu Hengrui Medicine, INNOVENT BIOLOGICS(SUZHOU), Betta Pharmaceuticals, Remegen Co.,Ltd., Shanghai Allist Pharmaceuticals, Innocare, Huiyu Pharmaceuticals

What are the Application segmentation covered in the Small Molecule Targeted Therapy Drugs Market report?

Ans: The Applications covered in the Small Molecule Targeted Therapy Drugs Market report are Cancer Diseases, Immune Diseases, Cardiovascular Diseases, Others

What are the Type segmentation covered in the Small Molecule Targeted Therapy Drugs Market report?

Ans: The Types covered in the Small Molecule Targeted Therapy Drugs Market report are Kinase Inhibitors, Others

1 Small Molecule Targeted Therapy Drugs Market Overview
1.1 Product Definition
1.2 Small Molecule Targeted Therapy Drugs by Type
1.2.1 Global Small Molecule Targeted Therapy Drugs Market Value by Type: 2025 vs 2032
1.2.2 Kinase Inhibitors
1.2.3 Others
1.3 Small Molecule Targeted Therapy Drugs by Administration Route
1.3.1 Global Small Molecule Targeted Therapy Drugs Market Value by Administration Route: 2025 vs 2032
1.3.2 Oral Drugs
1.3.3 Injectable Drugs
1.3.4 Others
1.4 Small Molecule Targeted Therapy Drugs by Raw Materials
1.4.1 Global Small Molecule Targeted Therapy Drugs Market Value by Raw Materials: 2025 vs 2032
1.4.2 Synthetic Drugs
1.4.3 Natural Drugs
1.5 Small Molecule Targeted Therapy Drugs by Application
1.5.1 Global Small Molecule Targeted Therapy Drugs Market Value by Application: 2025 vs 2032
1.5.2 Cancer Diseases
1.5.3 Immune Diseases
1.5.4 Cardiovascular Diseases
1.5.5 Others
1.6 Global Small Molecule Targeted Therapy Drugs Market Size Estimates and Forecasts
1.6.1 Global Small Molecule Targeted Therapy Drugs Revenue 2021–2032
1.6.2 Global Small Molecule Targeted Therapy Drugs Sales 2021–2032
1.6.3 Global Small Molecule Targeted Therapy Drugs Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Small Molecule Targeted Therapy Drugs Market Competition by Manufacturers
2.1 Global Small Molecule Targeted Therapy Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Small Molecule Targeted Therapy Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Small Molecule Targeted Therapy Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Small Molecule Targeted Therapy Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Small Molecule Targeted Therapy Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Small Molecule Targeted Therapy Drugs, Date of Entry into the Industry
2.8 Global Small Molecule Targeted Therapy Drugs Market Competitive Situation and Trends
2.8.1 Global Small Molecule Targeted Therapy Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Small Molecule Targeted Therapy Drugs Players Market Share by Revenue
2.8.3 Global Small Molecule Targeted Therapy Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Small Molecule Targeted Therapy Drugs Market Scenario by Region
3.1 Global Small Molecule Targeted Therapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Small Molecule Targeted Therapy Drugs Sales by Region: 2021–2032
3.2.1 Global Small Molecule Targeted Therapy Drugs Sales by Region: 2021–2026
3.2.2 Global Small Molecule Targeted Therapy Drugs Sales by Region: 2027–2032
3.3 Global Small Molecule Targeted Therapy Drugs Revenue by Region: 2021–2032
3.3.1 Global Small Molecule Targeted Therapy Drugs Revenue by Region: 2021–2026
3.3.2 Global Small Molecule Targeted Therapy Drugs Revenue by Region: 2027–2032
3.4 North America Small Molecule Targeted Therapy Drugs Market Facts & Figures by Country
3.4.1 North America Small Molecule Targeted Therapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Small Molecule Targeted Therapy Drugs Sales by Country (2021–2032)
3.4.3 North America Small Molecule Targeted Therapy Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Small Molecule Targeted Therapy Drugs Market Facts & Figures by Country
3.5.1 Europe Small Molecule Targeted Therapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Small Molecule Targeted Therapy Drugs Sales by Country (2021–2032)
3.5.3 Europe Small Molecule Targeted Therapy Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Small Molecule Targeted Therapy Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Small Molecule Targeted Therapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Small Molecule Targeted Therapy Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Small Molecule Targeted Therapy Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Small Molecule Targeted Therapy Drugs Market Facts & Figures by Country
3.7.1 Latin America Small Molecule Targeted Therapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Small Molecule Targeted Therapy Drugs Sales by Country (2021–2032)
3.7.3 Latin America Small Molecule Targeted Therapy Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Small Molecule Targeted Therapy Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Small Molecule Targeted Therapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Small Molecule Targeted Therapy Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Small Molecule Targeted Therapy Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Small Molecule Targeted Therapy Drugs Sales by Type (2021–2032)
4.1.1 Global Small Molecule Targeted Therapy Drugs Sales by Type (2021–2026)
4.1.2 Global Small Molecule Targeted Therapy Drugs Sales by Type (2027–2032)
4.1.3 Global Small Molecule Targeted Therapy Drugs Sales Market Share by Type (2021–2032)
4.2 Global Small Molecule Targeted Therapy Drugs Revenue by Type (2021–2032)
4.2.1 Global Small Molecule Targeted Therapy Drugs Revenue by Type (2021–2026)
4.2.2 Global Small Molecule Targeted Therapy Drugs Revenue by Type (2027–2032)
4.2.3 Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Small Molecule Targeted Therapy Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Small Molecule Targeted Therapy Drugs Sales by Application (2021–2032)
5.1.1 Global Small Molecule Targeted Therapy Drugs Sales by Application (2021–2026)
5.1.2 Global Small Molecule Targeted Therapy Drugs Sales by Application (2027–2032)
5.1.3 Global Small Molecule Targeted Therapy Drugs Sales Market Share by Application (2021–2032)
5.2 Global Small Molecule Targeted Therapy Drugs Revenue by Application (2021–2032)
5.2.1 Global Small Molecule Targeted Therapy Drugs Revenue by Application (2021–2026)
5.2.2 Global Small Molecule Targeted Therapy Drugs Revenue by Application (2027–2032)
5.2.3 Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Small Molecule Targeted Therapy Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Small Molecule Targeted Therapy Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Company Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novartis Small Molecule Targeted Therapy Drugs Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Merck Small Molecule Targeted Therapy Drugs Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfizer Small Molecule Targeted Therapy Drugs Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Company Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 AstraZeneca Small Molecule Targeted Therapy Drugs Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Company Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Johnson & Johnson Small Molecule Targeted Therapy Drugs Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Bristol Myers Squibb
6.7.1 Bristol Myers Squibb Company Information
6.7.2 Bristol Myers Squibb Description and Business Overview
6.7.3 Bristol Myers Squibb Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bristol Myers Squibb Small Molecule Targeted Therapy Drugs Product Portfolio
6.7.5 Bristol Myers Squibb Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Bayer Small Molecule Targeted Therapy Drugs Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 GSK
6.9.1 GSK Company Information
6.9.2 GSK Description and Business Overview
6.9.3 GSK Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 GSK Small Molecule Targeted Therapy Drugs Product Portfolio
6.9.5 GSK Recent Developments/Updates
6.10 Daiichi Sankyo
6.10.1 Daiichi Sankyo Company Information
6.10.2 Daiichi Sankyo Description and Business Overview
6.10.3 Daiichi Sankyo Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Daiichi Sankyo Small Molecule Targeted Therapy Drugs Product Portfolio
6.10.5 Daiichi Sankyo Recent Developments/Updates
6.11 Amgen
6.11.1 Amgen Company Information
6.11.2 Amgen Description and Business Overview
6.11.3 Amgen Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Amgen Small Molecule Targeted Therapy Drugs Product Portfolio
6.11.5 Amgen Recent Developments/Updates
6.12 Eli Lilly and Company
6.12.1 Eli Lilly and Company Company Information
6.12.2 Eli Lilly and Company Description and Business Overview
6.12.3 Eli Lilly and Company Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Eli Lilly and Company Small Molecule Targeted Therapy Drugs Product Portfolio
6.12.5 Eli Lilly and Company Recent Developments/Updates
6.13 AbbVie
6.13.1 AbbVie Company Information
6.13.2 AbbVie Description and Business Overview
6.13.3 AbbVie Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 AbbVie Small Molecule Targeted Therapy Drugs Product Portfolio
6.13.5 AbbVie Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Company Information
6.14.2 Sanofi Description and Business Overview
6.14.3 Sanofi Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Sanofi Small Molecule Targeted Therapy Drugs Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Takeda
6.15.1 Takeda Company Information
6.15.2 Takeda Description and Business Overview
6.15.3 Takeda Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Takeda Small Molecule Targeted Therapy Drugs Product Portfolio
6.15.5 Takeda Recent Developments/Updates
6.16 Boehringer Ingelheim
6.16.1 Boehringer Ingelheim Company Information
6.16.2 Boehringer Ingelheim Description and Business Overview
6.16.3 Boehringer Ingelheim Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Boehringer Ingelheim Small Molecule Targeted Therapy Drugs Product Portfolio
6.16.5 Boehringer Ingelheim Recent Developments/Updates
6.17 Beigene, Ltd.
6.17.1 Beigene, Ltd. Company Information
6.17.2 Beigene, Ltd. Description and Business Overview
6.17.3 Beigene, Ltd. Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Beigene, Ltd. Small Molecule Targeted Therapy Drugs Product Portfolio
6.17.5 Beigene, Ltd. Recent Developments/Updates
6.18 Jiangsu Hengrui Medicine
6.18.1 Jiangsu Hengrui Medicine Company Information
6.18.2 Jiangsu Hengrui Medicine Description and Business Overview
6.18.3 Jiangsu Hengrui Medicine Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Jiangsu Hengrui Medicine Small Molecule Targeted Therapy Drugs Product Portfolio
6.18.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.19 INNOVENT BIOLOGICS(SUZHOU)
6.19.1 INNOVENT BIOLOGICS(SUZHOU) Company Information
6.19.2 INNOVENT BIOLOGICS(SUZHOU) Description and Business Overview
6.19.3 INNOVENT BIOLOGICS(SUZHOU) Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 INNOVENT BIOLOGICS(SUZHOU) Small Molecule Targeted Therapy Drugs Product Portfolio
6.19.5 INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
6.20 Betta Pharmaceuticals
6.20.1 Betta Pharmaceuticals Company Information
6.20.2 Betta Pharmaceuticals Description and Business Overview
6.20.3 Betta Pharmaceuticals Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Betta Pharmaceuticals Small Molecule Targeted Therapy Drugs Product Portfolio
6.20.5 Betta Pharmaceuticals Recent Developments/Updates
6.21 Remegen Co.,Ltd.
6.21.1 Remegen Co.,Ltd. Company Information
6.21.2 Remegen Co.,Ltd. Description and Business Overview
6.21.3 Remegen Co.,Ltd. Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Remegen Co.,Ltd. Small Molecule Targeted Therapy Drugs Product Portfolio
6.21.5 Remegen Co.,Ltd. Recent Developments/Updates
6.22 Shanghai Allist Pharmaceuticals
6.22.1 Shanghai Allist Pharmaceuticals Company Information
6.22.2 Shanghai Allist Pharmaceuticals Description and Business Overview
6.22.3 Shanghai Allist Pharmaceuticals Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Shanghai Allist Pharmaceuticals Small Molecule Targeted Therapy Drugs Product Portfolio
6.22.5 Shanghai Allist Pharmaceuticals Recent Developments/Updates
6.23 Innocare
6.23.1 Innocare Company Information
6.23.2 Innocare Description and Business Overview
6.23.3 Innocare Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Innocare Small Molecule Targeted Therapy Drugs Product Portfolio
6.23.5 Innocare Recent Developments/Updates
6.24 Huiyu Pharmaceuticals
6.24.1 Huiyu Pharmaceuticals Company Information
6.24.2 Huiyu Pharmaceuticals Description and Business Overview
6.24.3 Huiyu Pharmaceuticals Small Molecule Targeted Therapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Huiyu Pharmaceuticals Small Molecule Targeted Therapy Drugs Product Portfolio
6.24.5 Huiyu Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Small Molecule Targeted Therapy Drugs Industry Chain Analysis
7.2 Small Molecule Targeted Therapy Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Small Molecule Targeted Therapy Drugs Production Mode & Process Analysis
7.4 Small Molecule Targeted Therapy Drugs Sales and Marketing
7.4.1 Small Molecule Targeted Therapy Drugs Sales Channels
7.4.2 Small Molecule Targeted Therapy Drugs Distributors
7.5 Small Molecule Targeted Therapy Drugs Customer Analysis
8 Small Molecule Targeted Therapy Drugs Market Dynamics
8.1 Small Molecule Targeted Therapy Drugs Industry Trends
8.2 Small Molecule Targeted Therapy Drugs Market Drivers
8.3 Small Molecule Targeted Therapy Drugs Market Challenges
8.4 Small Molecule Targeted Therapy Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Small Molecule Targeted Therapy Drugs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Small Molecule Targeted Therapy Drugs Market Value by Administration Route (US$ Million), 2025 vs 2032
 Table 3. Global Small Molecule Targeted Therapy Drugs Market Value by Raw Materials (US$ Million), 2025 vs 2032
 Table 4. Global Small Molecule Targeted Therapy Drugs Market Value by Application (US$ Million), 2025 vs 2032
 Table 5. Global Small Molecule Targeted Therapy Drugs Market Competitive Situation by Manufacturers in 2025
 Table 6. Global Small Molecule Targeted Therapy Drugs Sales (M Units) of Key Manufacturers (2021–2026)
 Table 7. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Manufacturers (2021–2026)
 Table 8. Global Small Molecule Targeted Therapy Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 9. Global Small Molecule Targeted Therapy Drugs Revenue Share by Manufacturers (2021–2026)
 Table 10. Global Market Small Molecule Targeted Therapy Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 11. Global Key Players of Small Molecule Targeted Therapy Drugs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 12. Global Key Manufacturers of Small Molecule Targeted Therapy Drugs, Manufacturing Sites and Headquarters
 Table 13. Global Key Manufacturers of Small Molecule Targeted Therapy Drugs, Product Types and Applications
 Table 14. Global Key Manufacturers of Small Molecule Targeted Therapy Drugs, Date of Entry into the Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Small Molecule Targeted Therapy Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Small Molecule Targeted Therapy Drugs Revenue, 2025
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Small Molecule Targeted Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 19. Global Small Molecule Targeted Therapy Drugs Sales by Region (M Units), 2021–2026
 Table 20. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Region (2021–2026)
 Table 21. Global Small Molecule Targeted Therapy Drugs Sales by Region (M Units), 2027–2032
 Table 22. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Region (2027–2032)
 Table 23. Global Small Molecule Targeted Therapy Drugs Revenue by Region (US$ Million), 2021–2026
 Table 24. Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Region (2021–2026)
 Table 25. Global Small Molecule Targeted Therapy Drugs Revenue by Region (US$ Million), 2027–2032
 Table 26. Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Region (2027–2032)
 Table 27. North America Small Molecule Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 28. North America Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
 Table 29. North America Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
 Table 30. North America Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 31. North America Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 32. Europe Small Molecule Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 33. Europe Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
 Table 34. Europe Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
 Table 35. Europe Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 36. Europe Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 37. Asia Pacific Small Molecule Targeted Therapy Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 38. Asia Pacific Small Molecule Targeted Therapy Drugs Sales by Region (M Units), 2021–2026
 Table 39. Asia Pacific Small Molecule Targeted Therapy Drugs Sales by Region (M Units), 2027–2032
 Table 40. Asia Pacific Small Molecule Targeted Therapy Drugs Revenue by Region (US$ Million), 2021–2026
 Table 41. Asia Pacific Small Molecule Targeted Therapy Drugs Revenue by Region (US$ Million), 2027–2032
 Table 42. Latin America Small Molecule Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 43. Latin America Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
 Table 44. Latin America Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
 Table 45. Latin America Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 46. Latin America Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 47. Middle East and Africa Small Molecule Targeted Therapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 48. Middle East and Africa Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2021–2026
 Table 49. Middle East and Africa Small Molecule Targeted Therapy Drugs Sales by Country (M Units), 2027–2032
 Table 50. Middle East and Africa Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 51. Middle East and Africa Small Molecule Targeted Therapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 52. Global Small Molecule Targeted Therapy Drugs Sales (M Units) by Type (2021–2026)
 Table 53. Global Small Molecule Targeted Therapy Drugs Sales (M Units) by Type (2027–2032)
 Table 54. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Type (2021–2026)
 Table 55. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Type (2027–2032)
 Table 56. Global Small Molecule Targeted Therapy Drugs Revenue (US$ Million) by Type (2021–2026)
 Table 57. Global Small Molecule Targeted Therapy Drugs Revenue (US$ Million) by Type (2027–2032)
 Table 58. Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Type (2021–2026)
 Table 59. Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Type (2027–2032)
 Table 60. Global Small Molecule Targeted Therapy Drugs Price (US$/Unit) by Type (2021–2026)
 Table 61. Global Small Molecule Targeted Therapy Drugs Price (US$/Unit) by Type (2027–2032)
 Table 62. Global Small Molecule Targeted Therapy Drugs Sales (M Units) by Application (2021–2026)
 Table 63. Global Small Molecule Targeted Therapy Drugs Sales (M Units) by Application (2027–2032)
 Table 64. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Application (2021–2026)
 Table 65. Global Small Molecule Targeted Therapy Drugs Sales Market Share by Application (2027–2032)
 Table 66. Global Small Molecule Targeted Therapy Drugs Revenue (US$ Million) by Application (2021–2026)
 Table 67. Global Small Molecule Targeted Therapy Drugs Revenue (US$ Million) by Application (2027–2032)
 Table 68. Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Application (2021–2026)
 Table 69. Global Small Molecule Targeted Therapy Drugs Revenue Market Share by Application (2027–2032)
 Table 70. Global Small Molecule Targeted Therapy Drugs Price (US$/Unit) by Application (2021–2026)
 Table 71. Global Small Molecule Targeted Therapy Drugs Price (US$/Unit) by Application (2027–2032)
 Table 72. Roche Company Information
 Table 73. Roche Description and Business Overview
 Table 74. Roche Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 75. Roche Small Molecule Targeted Therapy Drugs Product
 Table 76. Roche Recent Developments/Updates
 Table 77. Novartis Company Information
 Table 78. Novartis Description and Business Overview
 Table 79. Novartis Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 80. Novartis Small Molecule Targeted Therapy Drugs Product
 Table 81. Novartis Recent Developments/Updates
 Table 82. Merck Company Information
 Table 83. Merck Description and Business Overview
 Table 84. Merck Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 85. Merck Small Molecule Targeted Therapy Drugs Product
 Table 86. Merck Recent Developments/Updates
 Table 87. Pfizer Company Information
 Table 88. Pfizer Description and Business Overview
 Table 89. Pfizer Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 90. Pfizer Small Molecule Targeted Therapy Drugs Product
 Table 91. Pfizer Recent Developments/Updates
 Table 92. AstraZeneca Company Information
 Table 93. AstraZeneca Description and Business Overview
 Table 94. AstraZeneca Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 95. AstraZeneca Small Molecule Targeted Therapy Drugs Product
 Table 96. AstraZeneca Recent Developments/Updates
 Table 97. Johnson & Johnson Company Information
 Table 98. Johnson & Johnson Description and Business Overview
 Table 99. Johnson & Johnson Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 100. Johnson & Johnson Small Molecule Targeted Therapy Drugs Product
 Table 101. Johnson & Johnson Recent Developments/Updates
 Table 102. Bristol Myers Squibb Company Information
 Table 103. Bristol Myers Squibb Description and Business Overview
 Table 104. Bristol Myers Squibb Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 105. Bristol Myers Squibb Small Molecule Targeted Therapy Drugs Product
 Table 106. Bristol Myers Squibb Recent Developments/Updates
 Table 107. Bayer Company Information
 Table 108. Bayer Description and Business Overview
 Table 109. Bayer Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 110. Bayer Small Molecule Targeted Therapy Drugs Product
 Table 111. Bayer Recent Developments/Updates
 Table 112. GSK Company Information
 Table 113. GSK Description and Business Overview
 Table 114. GSK Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 115. GSK Small Molecule Targeted Therapy Drugs Product
 Table 116. GSK Recent Developments/Updates
 Table 117. Daiichi Sankyo Company Information
 Table 118. Daiichi Sankyo Description and Business Overview
 Table 119. Daiichi Sankyo Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 120. Daiichi Sankyo Small Molecule Targeted Therapy Drugs Product
 Table 121. Daiichi Sankyo Recent Developments/Updates
 Table 122. Amgen Company Information
 Table 123. Amgen Description and Business Overview
 Table 124. Amgen Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 125. Amgen Small Molecule Targeted Therapy Drugs Product
 Table 126. Amgen Recent Developments/Updates
 Table 127. Eli Lilly and Company Company Information
 Table 128. Eli Lilly and Company Description and Business Overview
 Table 129. Eli Lilly and Company Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 130. Eli Lilly and Company Small Molecule Targeted Therapy Drugs Product
 Table 131. Eli Lilly and Company Recent Developments/Updates
 Table 132. AbbVie Company Information
 Table 133. AbbVie Description and Business Overview
 Table 134. AbbVie Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 135. AbbVie Small Molecule Targeted Therapy Drugs Product
 Table 136. AbbVie Recent Developments/Updates
 Table 137. Sanofi Company Information
 Table 138. Sanofi Description and Business Overview
 Table 139. Sanofi Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 140. Sanofi Small Molecule Targeted Therapy Drugs Product
 Table 141. Sanofi Recent Developments/Updates
 Table 142. Takeda Company Information
 Table 143. Takeda Description and Business Overview
 Table 144. Takeda Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 145. Takeda Small Molecule Targeted Therapy Drugs Product
 Table 146. Takeda Recent Developments/Updates
 Table 147. Boehringer Ingelheim Company Information
 Table 148. Boehringer Ingelheim Description and Business Overview
 Table 149. Boehringer Ingelheim Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 150. Boehringer Ingelheim Small Molecule Targeted Therapy Drugs Product
 Table 151. Boehringer Ingelheim Recent Developments/Updates
 Table 152. Beigene, Ltd. Company Information
 Table 153. Beigene, Ltd. Description and Business Overview
 Table 154. Beigene, Ltd. Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 155. Beigene, Ltd. Small Molecule Targeted Therapy Drugs Product
 Table 156. Beigene, Ltd. Recent Developments/Updates
 Table 157. Jiangsu Hengrui Medicine Company Information
 Table 158. Jiangsu Hengrui Medicine Description and Business Overview
 Table 159. Jiangsu Hengrui Medicine Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 160. Jiangsu Hengrui Medicine Small Molecule Targeted Therapy Drugs Product
 Table 161. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 162. INNOVENT BIOLOGICS(SUZHOU) Company Information
 Table 163. INNOVENT BIOLOGICS(SUZHOU) Description and Business Overview
 Table 164. INNOVENT BIOLOGICS(SUZHOU) Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 165. INNOVENT BIOLOGICS(SUZHOU) Small Molecule Targeted Therapy Drugs Product
 Table 166. INNOVENT BIOLOGICS(SUZHOU) Recent Developments/Updates
 Table 167. Betta Pharmaceuticals Company Information
 Table 168. Betta Pharmaceuticals Description and Business Overview
 Table 169. Betta Pharmaceuticals Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 170. Betta Pharmaceuticals Small Molecule Targeted Therapy Drugs Product
 Table 171. Betta Pharmaceuticals Recent Developments/Updates
 Table 172. Remegen Co.,Ltd. Company Information
 Table 173. Remegen Co.,Ltd. Description and Business Overview
 Table 174. Remegen Co.,Ltd. Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 175. Remegen Co.,Ltd. Small Molecule Targeted Therapy Drugs Product
 Table 176. Remegen Co.,Ltd. Recent Developments/Updates
 Table 177. Shanghai Allist Pharmaceuticals Company Information
 Table 178. Shanghai Allist Pharmaceuticals Description and Business Overview
 Table 179. Shanghai Allist Pharmaceuticals Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 180. Shanghai Allist Pharmaceuticals Small Molecule Targeted Therapy Drugs Product
 Table 181. Shanghai Allist Pharmaceuticals Recent Developments/Updates
 Table 182. Innocare Company Information
 Table 183. Innocare Description and Business Overview
 Table 184. Innocare Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 185. Innocare Small Molecule Targeted Therapy Drugs Product
 Table 186. Innocare Recent Developments/Updates
 Table 187. Huiyu Pharmaceuticals Company Information
 Table 188. Huiyu Pharmaceuticals Description and Business Overview
 Table 189. Huiyu Pharmaceuticals Small Molecule Targeted Therapy Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 190. Huiyu Pharmaceuticals Small Molecule Targeted Therapy Drugs Product
 Table 191. Huiyu Pharmaceuticals Recent Developments/Updates
 Table 192. Key Raw Materials Lists
 Table 193. Raw Materials Key Suppliers Lists
 Table 194. Small Molecule Targeted Therapy Drugs Distributors List
 Table 195. Small Molecule Targeted Therapy Drugs Customers List
 Table 196. Small Molecule Targeted Therapy Drugs Market Trends
 Table 197. Small Molecule Targeted Therapy Drugs Market Drivers
 Table 198. Small Molecule Targeted Therapy Drugs Market Challenges
 Table 199. Small Molecule Targeted Therapy Drugs Market Restraints
 Table 200. Research Programs/Design for This Report
 Table 201. Key Data Information from Secondary Sources
 Table 202. Key Data Information from Primary Sources
 Table 203. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Small Molecule Targeted Therapy Drugs
 Figure 2. Global Small Molecule Targeted Therapy Drugs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Small Molecule Targeted Therapy Drugs Market Share by Type: 2025 & 2032
 Figure 4. Kinase Inhibitors Product Picture
 Figure 5. Others Product Picture
 Figure 6. Global Small Molecule Targeted Therapy Drugs Market Value by Administration Route (US$ Million), 2021–2032
 Figure 7. Global Small Molecule Targeted Therapy Drugs Market Share by Administration Route: 2025 vs 2032
 Figure 8. Oral Drugs Product Picture
 Figure 9. Injectable Drugs Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Small Molecule Targeted Therapy Drugs Market Value by Raw Materials (US$ Million), 2021–2032
 Figure 12. Global Small Molecule Targeted Therapy Drugs Market Share by Raw Materials: 2025 vs 2032
 Figure 13. Synthetic Drugs Product Picture
 Figure 14. Natural Drugs Product Picture
 Figure 15. Global Small Molecule Targeted Therapy Drugs Market Value by Application (US$ Million), 2021–2032
 Figure 16. Global Small Molecule Targeted Therapy Drugs Market Share by Application: 2025 & 2032
 Figure 17. Cancer Diseases
 Figure 18. Immune Diseases
 Figure 19. Cardiovascular Diseases
 Figure 20. Others
 Figure 21. Global Small Molecule Targeted Therapy Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 22. Global Small Molecule Targeted Therapy Drugs Market Size (US$ Million), 2021–2032
 Figure 23. Global Small Molecule Targeted Therapy Drugs Sales (M Units), 2021–2032
 Figure 24. Global Small Molecule Targeted Therapy Drugs Average Price (US$/Unit), 2021–2032
 Figure 25. Small Molecule Targeted Therapy Drugs Report Years Considered
 Figure 26. Small Molecule Targeted Therapy Drugs Sales Share by Manufacturers in 2025
 Figure 27. Global Small Molecule Targeted Therapy Drugs Revenue Share by Manufacturers in 2025
 Figure 28. Top 5 and Top 10 Global Small Molecule Targeted Therapy Drugs Players: Market Share by Revenue in Small Molecule Targeted Therapy Drugs in 2025
 Figure 29. Small Molecule Targeted Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 30. Global Small Molecule Targeted Therapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 31. North America Small Molecule Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
 Figure 32. North America Small Molecule Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 33. United States Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Canada Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Europe Small Molecule Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
 Figure 36. Europe Small Molecule Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 37. Germany Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. France Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. U.K. Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Italy Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Russia Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Asia Pacific Small Molecule Targeted Therapy Drugs Sales Market Share by Region (2021–2032)
 Figure 43. Asia Pacific Small Molecule Targeted Therapy Drugs Revenue Market Share by Region (2021–2032)
 Figure 44. China Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Japan Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. South Korea Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. India Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Australia Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. China Taiwan Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Southeast Asia Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Latin America Small Molecule Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
 Figure 52. Latin America Small Molecule Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 53. Mexico Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Brazil Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Argentina Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. Colombia Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Middle East and Africa Small Molecule Targeted Therapy Drugs Sales Market Share by Country (2021–2032)
 Figure 58. Middle East and Africa Small Molecule Targeted Therapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 59. Turkey Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Saudi Arabia Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 61. UAE Small Molecule Targeted Therapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 62. Global Sales Market Share of Small Molecule Targeted Therapy Drugs by Type (2021–2032)
 Figure 63. Global Revenue Market Share of Small Molecule Targeted Therapy Drugs by Type (2021–2032)
 Figure 64. Global Small Molecule Targeted Therapy Drugs Price (US$/Unit) by Type (2021–2032)
 Figure 65. Global Sales Market Share of Small Molecule Targeted Therapy Drugs by Application (2021–2032)
 Figure 66. Global Revenue Market Share of Small Molecule Targeted Therapy Drugs by Application (2021–2032)
 Figure 67. Global Small Molecule Targeted Therapy Drugs Price (US$/Unit) by Application (2021–2032)
 Figure 68. Small Molecule Targeted Therapy Drugs Value Chain
 Figure 69. Channels of Distribution (Direct Vs Distribution)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS